eRapa™ for the Treatment of
Rare Genetic Diseases & Cancer
Employees: 11-50
Total raised: $19.9M
Founded date: 2012
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.08.2022 | Grant | $16.9M | - |
| 27.08.2019 | Grant | $3M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 26.04.2024 | Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 R... | April 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Biodexa Enters Into Exclusiv... | einpresswi... |
| 20.08.2022 | Emtora Biosciences Receives $16.9M Grant from the Cancer Pre... | Emtora Biosciences, a San Antonio, Texas-based clinical-stage biopharmaceutical company, has been aw... | finsmes.co... |
| 27.08.2019 | Emtora Biosciences Receives $3M CPRIT Grant | Emtora Biosciences, a San Antonio, Texas-based clinical stage life science company, will receive a S... | finsmes.co... |